Phenobarbital 30mg Tablets

Manufacturer HIKMA Active Ingredient Phenobarbital Tablets(fee noe BAR bi tal) Pronunciation fee noe BAR bi tal
WARNING: The use of this drug along with opioid drugs may lead to severe side effects. This includes feeling very sleepy, slow or trouble breathing, passing out, and death. Opioid drugs include drugs like codeine, oxycodone, and morphine. Opioid drugs are used to treat pain and some are used to treat cough. If you have questions, talk with the doctor.If you are taking this drug with an opioid drug, get medical help right away if you feel very sleepy or dizzy; if you have slow, shallow, or trouble breathing; or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up. Using this drug for reasons that are not approved may increase the risk for drug use disorder. Misuse or abuse of this drug can lead to overdose or death, especially if used with certain other drugs, alcohol, or street drugs. Get medical help right away if you have changes in mood or behavior, suicidal thoughts or actions, seizures, or trouble breathing. @ COMMON USES: It is used to help control certain kinds of seizures.It is used to treat sleep problems.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Anticonvulsant; Sedative-Hypnotic
đŸ§Ŧ
Pharmacologic Class
Barbiturate
🤰
Pregnancy Category
Category D
✅
FDA Approved
Jan 1939
âš–ī¸
DEA Schedule
Schedule IV

Overview

â„šī¸

What is this medicine?

Phenobarbital is a medication that works on your brain to help control seizures or to make you feel calm and sleepy. It's a type of drug called a barbiturate. It slows down your brain activity.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication as directed, with or without food. If you experience stomach upset, taking it with food may help.

Storing and Disposing of Your Medication

Keep your medication at room temperature, away from light and moisture. Store it in a dry place, avoiding bathrooms and areas where children or pets can access it. Keep the container tightly closed and store it in a secure location, such as a locked box or cabinet, to prevent accidental ingestion or misuse by others.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Do not stop taking this medication suddenly, especially if you have epilepsy, as it can cause severe withdrawal symptoms or seizures. Your doctor will guide you on how to slowly reduce the dose if needed.
  • Avoid alcohol and other medications that make you drowsy (like cold medicines, pain relievers, or other sedatives) while taking phenobarbital, as this can increase drowsiness and breathing problems.
  • Be careful when driving or operating machinery until you know how this medication affects you, as it can cause dizziness, drowsiness, or blurred vision.
  • If you are taking birth control pills, phenobarbital can make them less effective. Discuss alternative birth control methods with your doctor.
  • Maintain good oral hygiene, as some anticonvulsants can cause gum overgrowth.
  • Report any unusual skin rashes, fever, sore throat, or yellowing of the skin/eyes to your doctor immediately.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Epilepsy: 60-200 mg/day orally, once daily or in divided doses. Sedation: 30-120 mg/day orally, in 2-3 divided doses.
Dose Range: 30 - 200 mg

Condition-Specific Dosing:

epilepsy: Initial: 60-100 mg/day, adjusted based on clinical response and plasma levels (15-40 mcg/mL).
sedation: 30-120 mg/day in 2-3 divided doses.
hypnotic: 100-320 mg at bedtime.
đŸ‘ļ

Pediatric Dosing

Neonatal: Loading dose: 15-20 mg/kg IV/PO. Maintenance: 3-4 mg/kg/day in 1-2 divided doses.
Infant: Loading dose: 15-20 mg/kg IV/PO. Maintenance: 3-5 mg/kg/day in 1-2 divided doses.
Child: Loading dose: 15-20 mg/kg IV/PO. Maintenance: 3-6 mg/kg/day in 1-2 divided doses (max 12 mg/kg/day or 400 mg/day).
Adolescent: Epilepsy: 1-6 mg/kg/day or 50-100 mg/m2/day orally, once daily or in divided doses.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment, monitor for increased sedation.
Moderate: Consider dose reduction by 25-50%, monitor plasma levels and clinical response.
Severe: Significant dose reduction (e.g., 50-75%), monitor plasma levels closely. Avoid if possible.
Dialysis: Hemodialysis removes phenobarbital; supplemental dose may be needed post-dialysis. Peritoneal dialysis removes phenobarbital to a lesser extent.

Hepatic Impairment:

Mild: Use with caution, monitor for increased sedation and toxicity.
Moderate: Consider dose reduction by 25-50%, monitor plasma levels and clinical response. Avoid if possible.
Severe: Contraindicated in severe hepatic impairment due to risk of coma and increased toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Phenobarbital is a barbiturate that produces nonselective depression of the central nervous system (CNS). It binds to the GABA-A receptor complex, enhancing the inhibitory effects of GABA by increasing the duration of chloride channel opening. This leads to hyperpolarization of the neuronal membrane, decreasing neuronal excitability and raising the seizure threshold. It also inhibits excitatory neurotransmitter release.
📊

Pharmacokinetics

Absorption:

Bioavailability: 80-100%
Tmax: Oral: 8-12 hours (range 2-18 hours)
FoodEffect: Food may slightly delay absorption but does not significantly affect bioavailability.

Distribution:

Vd: 0.5-1 L/kg (adults); 0.7-1 L/kg (children)
ProteinBinding: 20-45%
CnssPenetration: Yes (readily crosses blood-brain barrier)

Elimination:

HalfLife: Adults: 53-118 hours (average 79 hours); Children: 37-73 hours; Neonates: 100-500 hours
Clearance: 0.003-0.007 L/kg/hr
ExcretionRoute: Renal (25-50% as unchanged drug, remainder as metabolites)
Unchanged: 25-50%
âąī¸

Pharmacodynamics

OnsetOfAction: Oral: 30-60 minutes; IV: <5 minutes
PeakEffect: Oral: 8-12 hours; IV: 30 minutes
DurationOfAction: 6-10 hours (sedative effects); Anticonvulsant effects persist longer due to long half-life.

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Feeling confused
Change in balance
Muscle spasm
Bad dreams
Restlessness
Hallucinations (seeing or hearing things that are not there)
Shortness of breath
Slow heartbeat
Feeling very tired or weak
Severe dizziness or passing out

Severe Skin Reaction: Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

This rare but serious condition can cause severe health problems and may be life-threatening. Seek medical help immediately if you experience:

Red, swollen, blistered, or peeling skin (with or without fever)
Red or irritated eyes
Sores in your mouth, throat, nose, or eyes

Severe and Potentially Deadly Effect

In rare cases, people taking seizure medications like this one may experience a severe and potentially deadly effect. Contact your doctor right away if you notice:

Swollen glands
Fever
Rash
Painful sores in the mouth or around the eyes
Chest pain
Signs of kidney problems, such as:
+ Unable to pass urine
+ Change in the amount of urine passed
Signs of liver problems, such as:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Throwing up
+ Yellow skin or eyes

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you notice any of the following:

Feeling dizzy or sleepy
Headache
Upset stomach or throwing up
Constipation
Feeling nervous and excitable
* Trouble sleeping

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe skin rash, blistering, or peeling (could be Stevens-Johnson syndrome or toxic epidermal necrolysis)
  • Difficulty breathing or very slow breathing
  • Extreme drowsiness or difficulty waking up
  • Unusual bleeding or bruising
  • Yellowing of the skin or eyes (jaundice)
  • Dark urine or pale stools
  • Persistent fever or sore throat
  • Confusion, hallucinations, or unusual thoughts/behavior
  • Increased seizures or new types of seizures
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, such as liver disease or breathing difficulties like shortness of breath.
A history of porphyria, a disorder that affects the production of heme.
Heart-related problems, including:
+ Heart failure
+ Unstable angina (a type of chest pain)
+ Abnormal heartbeat, such as long QT interval on an electrocardiogram (ECG)
+ Recent heart attack
Kidney disease
Low thyroid function (hypothyroidism)
A very narrow heart valve (aortic stenosis)

Additionally, inform your doctor if you are taking any medications that can cause abnormal heart rhythms, specifically those that prolong the QT interval. Many medications can have this effect, so it is crucial to consult with your doctor or pharmacist if you are unsure.

To ensure your safety, provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter medications you are taking
Natural products and vitamins you are using
Any health problems you have

This information will help your doctor determine whether it is safe for you to take this medication with your existing health conditions and medications. Never start, stop, or change the dose of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, about your treatment.

Risk of Dependence and Withdrawal
The longer you take this medication and the higher the dose, the greater your risk of dependence and withdrawal. Before reducing the dose or stopping this medication, consult your doctor and follow their instructions carefully. Abruptly lowering the dose or stopping this medication can lead to withdrawal, which may be life-threatening. Seek immediate medical attention if you experience any adverse effects.

Tolerance
If you have been taking this medication for an extended period or at high doses, you may develop tolerance, requiring higher doses to achieve the same effect. If you notice this medication is not working as well as it previously did, contact your doctor. Do not take more than the prescribed dose.

Monitoring and Precautions
If you are taking this medication long-term, your doctor may recommend regular blood tests. Discuss this with your doctor. Until you understand how this medication affects you, avoid driving and other activities that require alertness. Additionally, refrain from consuming alcohol while taking this medication.

Interactions with Other Substances
Before using marijuana, other forms of cannabis, or prescription or over-the-counter drugs that may cause drowsiness, consult your doctor.

Suicidal Thoughts or Actions
Like other medications used to treat seizures, this drug may rarely increase the risk of suicidal thoughts or actions, particularly in individuals with a history of such thoughts or actions. Immediately contact your doctor if you experience new or worsening symptoms, such as depression, anxiety, restlessness, irritability, panic attacks, or mood changes. If you have suicidal thoughts or actions, seek medical attention right away.

Special Considerations

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.
Birth control pills and other hormone-based birth control methods may be less effective while taking this medication. Use two forms of birth control to prevent pregnancy.
If you are pregnant or become pregnant while taking this medication, contact your doctor immediately, as it may harm the unborn baby.
Taking this medication during the third trimester of pregnancy may lead to side effects or withdrawal in the newborn.
If you are breastfeeding, discuss the risks to your baby with your doctor.

Seizure-Specific Warnings
If your seizures change or worsen after starting this medication, consult your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Slow, shallow breathing (respiratory depression)
  • Low blood pressure (hypotension)
  • Slow heart rate (bradycardia)
  • Hypothermia (low body temperature)
  • Pulmonary edema
  • Kidney failure
  • Shock

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment may involve supportive care, activated charcoal, and in severe cases, hemodialysis.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Porphyria (acute intermittent porphyria)
  • Severe respiratory depression
  • Severe hepatic impairment
🔴

Major Interactions

  • Other CNS depressants (alcohol, opioids, benzodiazepines, tricyclic antidepressants): Increased sedation, respiratory depression.
  • Valproic acid, felbamate: Increased phenobarbital levels due to enzyme inhibition.
  • Oral contraceptives, warfarin, corticosteroids, doxycycline, quinidine, lamotrigine, tiagabine, topiramate, zonisamide: Decreased efficacy due to phenobarbital's enzyme induction.
  • Griseofulvin, metronidazole: Decreased efficacy.
  • MAO inhibitors: Prolonged phenobarbital effects.
🟡

Moderate Interactions

  • Acetaminophen: Increased risk of hepatotoxicity with chronic phenobarbital use.
  • Antihistamines: Additive CNS depression.
  • Rifampin: Decreased phenobarbital levels.
  • Theophylline/Aminophylline: Decreased levels of theophylline/aminophylline.
  • Vitamin D: May increase vitamin D requirements.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Complete Blood Count (CBC)

Rationale: To establish baseline and monitor for blood dyscrasias (e.g., megaloblastic anemia, agranulocytosis).

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: To establish baseline and monitor for hepatic toxicity.

Timing: Prior to initiation

Renal Function Tests (BUN, Creatinine)

Rationale: To establish baseline and guide dosing in renal impairment.

Timing: Prior to initiation

Serum Phenobarbital Levels

Rationale: To establish baseline and guide initial dosing, especially in epilepsy.

Timing: Prior to initiation (optional, but useful)

📊

Routine Monitoring

Serum Phenobarbital Levels

Frequency: Weekly during initial titration, then every 1-3 months until stable, then every 6-12 months or as clinically indicated.

Target: 15-40 mcg/mL (for epilepsy); 5-15 mcg/mL (for sedation)

Action Threshold: Levels >40 mcg/mL often associated with toxicity; levels <15 mcg/mL may indicate subtherapeutic dosing for epilepsy.

Liver Function Tests (LFTs)

Frequency: Every 6-12 months, or if symptoms of hepatic dysfunction occur.

Target: Within normal limits

Action Threshold: Significant elevation (e.g., >3x ULN) warrants investigation and potential dose adjustment/discontinuation.

Complete Blood Count (CBC)

Frequency: Every 6-12 months, or if symptoms of hematologic abnormalities occur.

Target: Within normal limits

Action Threshold: Significant abnormalities (e.g., severe anemia, leukopenia, thrombocytopenia) warrant investigation.

Clinical Assessment (sedation, cognitive function, mood)

Frequency: At each visit

Target: Not applicable

Action Threshold: Excessive sedation, ataxia, nystagmus, cognitive impairment, or mood changes may indicate toxicity or need for dose adjustment.

đŸ‘ī¸

Symptom Monitoring

  • Excessive sedation or drowsiness
  • Dizziness or lightheadedness
  • Ataxia (unsteadiness)
  • Nystagmus (involuntary eye movements)
  • Cognitive impairment (memory, concentration)
  • Skin rash or allergic reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis)
  • Changes in mood or behavior (e.g., irritability, hyperactivity in children)
  • Respiratory depression (slow, shallow breathing)
  • Signs of liver dysfunction (e.g., jaundice, dark urine, abdominal pain)
  • Signs of blood dyscrasias (e.g., unusual bruising, bleeding, fever, sore throat)

Special Patient Groups

🤰

Pregnancy

Phenobarbital is classified as Pregnancy Category D. It is a known human teratogen associated with an increased risk of congenital malformations (e.g., cleft lip/palate, cardiac defects, neural tube defects) and a 'fetal anticonvulsant syndrome' characterized by craniofacial abnormalities, digital hypoplasia, and developmental delay. It can also cause neonatal withdrawal symptoms and hemorrhagic disease of the newborn (due to vitamin K deficiency). Use only if the potential benefit outweighs the risk, and consider vitamin K supplementation for the mother in the last month of pregnancy.

Trimester-Specific Risks:

First Trimester: Highest risk for major congenital malformations.
Second Trimester: Continued risk for developmental abnormalities.
Third Trimester: Risk of neonatal withdrawal syndrome (irritability, tremors, hypertonia, feeding difficulties) and hemorrhagic disease of the newborn.
🤱

Lactation

Phenobarbital is excreted into breast milk and is rated L3 (Moderately Safe) by Hale's classification. It can cause sedation, poor feeding, and withdrawal symptoms in breastfed infants, especially in neonates or with high maternal doses. Monitor the infant for drowsiness, poor suckling, and developmental milestones. Consider alternative agents or careful monitoring if phenobarbital use is necessary.

Infant Risk: Moderate risk of adverse effects (sedation, poor feeding, withdrawal) in the infant. Risk is higher in neonates and with higher maternal doses.
đŸ‘ļ

Pediatric Use

Children, especially younger ones, may exhibit paradoxical hyperactivity or irritability. Close monitoring of plasma levels is crucial due to variable metabolism and long half-life. Long-term use may affect cognitive development and bone health (requiring vitamin D supplementation).

👴

Geriatric Use

Elderly patients are more sensitive to the sedative and CNS depressant effects of phenobarbital. They are at increased risk for falls, confusion, and respiratory depression. Lower initial doses and slower titration are recommended. Monitor closely for adverse effects.

Clinical Information

💎

Clinical Pearls

  • Phenobarbital has a very long half-life, meaning it takes a long time to reach steady state (weeks) and to be eliminated from the body. This allows for once-daily dosing but also means dose adjustments take time to show full effect and toxicity can be prolonged.
  • Therapeutic drug monitoring (TDM) is essential for phenobarbital, especially for epilepsy, to optimize efficacy and minimize toxicity. Target levels are typically 15-40 mcg/mL.
  • Due to its potent enzyme-inducing properties, phenobarbital has numerous significant drug interactions, particularly with oral contraceptives, warfarin, and other anticonvulsants. Always review concomitant medications.
  • Abrupt discontinuation can precipitate severe withdrawal symptoms, including status epilepticus, especially in patients treated for epilepsy. Tapering is crucial.
  • While effective, its sedative side effects and cognitive impairment potential often make it a second or third-line agent for epilepsy compared to newer anticonvulsants.
  • Phenobarbital is still a valuable agent for neonatal seizures and refractory status epilepticus.
🔄

Alternative Therapies

  • For Epilepsy: Levetiracetam, Valproic Acid, Lamotrigine, Carbamazepine, Oxcarbazepine, Topiramate, Gabapentin, Pregabalin, Lacosamide, Zonisamide, Rufinamide, Clobazam.
  • For Sedation/Anxiety (short-term): Benzodiazepines (e.g., Lorazepam, Diazepam, Alprazolam), Buspirone, Hydroxyzine.
  • For Insomnia: Z-drugs (e.g., Zolpidem, Eszopiclone), Benzodiazepines, Trazodone, Doxepin.
💰

Cost & Coverage

Average Cost: $10 - $50 per 30 tablets (30mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.